Virtual Affinity Fingerprints for Target Fishing: A New Application of Drug Profile Matching
暂无分享,去创建一个
Péter Hári | András Málnási-Csizmadia | Zoltán Simon | Ágnes Peragovics | László Tombor | Balázs Jelinek | Pál Czobor | P. Czobor | A. Málnási-Csizmadia | Péter Hári | Zoltán Simon | Ágnes Peragovics | Balázs Jelinek | L. Tombor
[1] I. Kuntz,et al. Molecular similarity based on DOCK-generated fingerprints. , 1996, Journal of medicinal chemistry.
[2] H. Wikström,et al. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation. , 1999, Journal of medicinal chemistry.
[3] M. Kukla,et al. Pyrrole mannich bases as potential antipsychotic agents. , 1992, Journal of Medicinal Chemistry.
[4] E. Richelson. Neuroleptic Binding to Human Brain Receptors: Relation to Clinical Effects a , 1988, Annals of the New York Academy of Sciences.
[5] Jaques Reifman,et al. DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0 , 2008, Chemistry Central journal.
[6] D. Sibley,et al. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs , 1995, Psychopharmacology.
[7] M. Teitler,et al. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. , 2000, The Journal of pharmacology and experimental therapeutics.
[8] Hans Briem,et al. Flexsim-X: A Method for the Detection of Molecules with Similar Biological Activity , 2000, J. Chem. Inf. Comput. Sci..
[9] Andreas Bender,et al. "Bayes Affinity Fingerprints" Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept? , 2006, J. Chem. Inf. Model..
[10] P. Seeman,et al. Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors , 1997, Neuropsychopharmacology.
[11] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[12] B. Roth,et al. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. , 1992, The Journal of pharmacology and experimental therapeutics.
[13] Csaba Hetényi,et al. Contribution of 2D and 3D Structural Features of Drug Molecules in the Prediction of Drug Profile Matching , 2012, J. Chem. Inf. Model..
[14] Kai Huang,et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach , 2010, Nucleic Acids Res..
[15] Xiaomin Luo,et al. TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..
[16] H. Yamamura,et al. Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line. , 1998, The Journal of pharmacology and experimental therapeutics.
[17] David S. Goodsell,et al. A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..
[18] Robert P Sheridan,et al. Why do we need so many chemical similarity search methods? , 2002, Drug discovery today.
[19] E. Richelson,et al. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. , 1984, European journal of pharmacology.
[20] Choong Yong Ung,et al. Can an in silico Drug‐Target Search Method Be Used to Probe Potential Mechanism of Medicinal Plant Ingredients? , 2003 .
[21] D. Bylund. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. , 1981, The Journal of pharmacology and experimental therapeutics.
[22] Z. Deng,et al. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. , 2006, Journal of medicinal chemistry.
[23] A. Poling,et al. Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure. , 1990, The Journal of pharmacology and experimental therapeutics.
[24] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[25] S. Snyder,et al. Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Black,et al. Antipsychotic drugs: prediction of side-effect profiles based on neuroreceptor data derived from human brain tissue. , 1987, Mayo Clinic proceedings.
[27] Christian C. Felder,et al. Muscarinic mechanisms of antipsychotic atypicality , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[28] R. Blakely,et al. Pharmacological profile of neuroleptics at human monoamine transporters. , 1999, European journal of pharmacology.
[29] B. Roth,et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.
[30] A. Harf,et al. Droperidol Prevents Serotonin‐Induced Bronchospasm in the Guinea Pig , 1991, Anesthesia and analgesia.
[31] P. Seeman,et al. Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors , 1998, Molecular Psychiatry.
[32] S. Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. , 1976, Science.
[33] David M. Rocke,et al. Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.
[34] Paul Ernsberger,et al. H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs , 2003, Neuropsychopharmacology.
[35] J. M. Kennedy,et al. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. , 1998, NIDA research monograph.
[36] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[37] E. Richelson,et al. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. , 1992, The Journal of pharmacology and experimental therapeutics.
[38] U. Lessel,et al. In vitro and in silico affinity fingerprints: Finding similarities beyond structural classes , 2000 .
[39] C. Wermuth. Selective optimization of side activities: another way for drug discovery. , 2004, Journal of medicinal chemistry.
[40] T. Liljefors,et al. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists. , 2003, Journal of medicinal chemistry.
[41] P. Hajduk,et al. Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks. , 2010, Current opinion in chemical biology.
[42] P. F. M. Janssen,et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding , 1996, Psychopharmacology.
[43] S. Snyder,et al. Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. , 1976, Molecular pharmacology.
[44] Y. Fukunishi,et al. Classification of chemical compounds by protein-compound docking for use in designing a focused library. , 2006, Journal of medicinal chemistry.
[45] Gergely Zahoránszky-Köhalmi,et al. Drug Effect Prediction by Polypharmacology-Based Interaction Profiling , 2012, J. Chem. Inf. Model..
[46] David W. Smith,et al. Synthesis and Biological Evaluation of 1-(1,2-Benzisothiazol-3-yl)- and (l,2-Benzisoxazol-3-yl)piperazine Derivatives as Potential Antipsychotic Agents. , 1986 .
[47] Anders Wallqvist,et al. Exploring Polypharmacology Using a ROCS-Based Target Fishing Approach , 2012, J. Chem. Inf. Model..
[48] J. Arnt,et al. Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence , 1998, Neuropsychopharmacology.
[49] Naomie Salim,et al. Combination of Fingerprint-Based Similarity Coefficients Using Data Fusion , 2003, J. Chem. Inf. Comput. Sci..
[50] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[51] E. Richelson,et al. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. , 2000, Life sciences.
[52] V. Poroikov,et al. PASS: identification of probable targets and mechanisms of toxicity , 2007, SAR and QSAR in environmental research.
[53] Luhua Lai,et al. Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..
[54] Andreas Bender,et al. From in silico target prediction to multi-target drug design: current databases, methods and applications. , 2011, Journal of proteomics.
[55] H O Villar,et al. Protein affinity map of chemical space. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[56] M. Millan,et al. Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptormediated phosphoinositide (PI) turnover by clozapine in the rat: A comparison to other antipsychotics , 1994, Neuroscience Letters.
[57] Haruki Nakamura,et al. An Efficient in Silico Screening Method Based on the Protein-Compound Affinity Matrix and Its Application to the Design of a Focused Library for Cytochrome P450 (CYP) Ligands , 2006, J. Chem. Inf. Model..
[58] Andreas Bender,et al. Ligand-Target Prediction Using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics , 2008, J. Chem. Inf. Model..